BRAINLIFE.ORG




Current Neuro-Oncology




Volume 26 Number 3
15 February 2024




Home > Publications > Current Neuro-Oncology > Volume 26, Year 2024 > Number 3, 15 February







*

Zhao L, Qiu Z, Yang Z, Xu L, Pearce TM, Wu Q, Yang K, Li F, Saulnier O, Fei F, Yu H, Gimple RC, Varadharajan V, Liu J, Hendrikse LD, Fong V, Wang W, Zhang J, Lv D, Lee D, Lehrich BM, Jin C, Ouyang L, Dixit D, Wu H, Wang X, Sloan AE, Wang X, Huan T, Mark Brown J, Goldman SA, Taylor MD, Zhou S, Rich JN.
Lymphatic endothelial-like cells promote glioblastoma stem cell growth through cytokine-driven cholesterol metabolism.
Nat Cancer. 2024 Jan 3;5(1):147-166. doi: 10.1038/s43018-023-00658-0. PMID: 38172338. Laboratory investigation˰ ˍ
Related article:
Brewer G.
Cholesterol-fuelled glioblastoma.
Nat Rev Cancer. 2024 Jan 31. doi: 10.1038/s41568-024-00672-z. PMID: 38297143. Comment˰ ˍ




Naeem A, Aziz N, Nasir M, Rangwala HS, Fatima H, Mubarak F.
Accuracy of MRI in Detecting 1p/19q Co-deletion Status of Gliomas: A Single-Center Retrospective Study.
Cureus. 2024 Jan 8;16(1):e51863. doi: 10.7759/cureus.51863. PMID: 38327950. Observational study. ˍ




Neef V, König S, Becker H, Dubinski D, Flinspach A, Raimann FJ, Weber K, Ronellenfitsch MW, Konczalla J, Hattingen E, Czabanka M, Senft C, Zacharowski K, Baumgarten P.
Red blood cell transfusion in patients undergoing elective primary glioblastoma resection.
Blood Transfus. 2024 Jan 11. doi: 10.2450/BloodTransfus.613. PMID: 38315541. Observational study. ˍ




van der Meulen M, Ramos RC, Voisin MR, Patil V, Wei Q, Singh O, Climans SA, Kalidindi N, Or R, Aldape K, Diamandis P, Munoz DG, Zadeh G, Mason WP.
Differences in methylation profiles between long-term survivors and short-term survivors of IDH-wild-type glioblastoma.
Neurooncol Adv. 2024 Jan 12;6(1):vdae001. doi: 10.1093/noajnl/vdae001. PMID: 38312227. Observational study. ˍ




Losurdo A, Dipasquale A, Giordano L, Persico P, Lorenzi E, Di Muzio A, Barigazzi C, Korolewicz J, Mehan A, Mohammed O, Scheiner B, Pinato DJ, Santoro A, Simonelli M.
Refining patient selection for next-generation immunotherapeutic early-phase clinical trials with a novel and externally validated prognostic nomogram.
Front Immunol. 2024 Jan 15;15:1323151. doi: 10.3389/fimmu.2024.1323151. PMID: 38298193. Observational study. ˍ




Goldlust SA, Nabors LB, Hsu S, Mohile N, Duic PJ, Benkers T, Singer S, Rao M, Cappello L, Silberman SL, Farmer G.
Phase 1 trial of TPI 287, a microtubule stabilizing agent, in combination with bevacizumab in adults with recurrent glioblastoma.
Neurooncol Adv. 2024 Jan 18;6(1):vdae009. doi: 10.1093/noajnl/vdae009. PMID: 38327681. Interventional study. ˍ




Orimoloye HT, Nguyen N, Deng C, Saechao C, Ritz B, Olsen J, Hansen J, Heck JE.
Maternal autoimmune disease and its association with childhood cancer: A population-based case-control study in Denmark.
EJC Paediatr Oncol. 2024 Jan 19;3:100145. doi: 10.1016/j.ejcped.2024.100145. PMID: 38298419. Observational study. ˍ




Hammoud M, Hmamouche OM, Lakhdar F, Benzagmout M, Chakour K, Chaoui MEF.
Pediatric extra-axial glioblastoma with bone invasion leading to a subcutaneous mass: A case report.
Surg Neurol Int. 2024 Jan 26;15:25. doi: 10.25259/SNI_809_2023. PMID: 38344102. Case report. ˍ




*Rossmeisl JH, King JN, Robertson JL, Weger-Lucarelli J, Elankumaran S.
Phase I/II Trial of Urokinase Plasminogen Activator-Targeted Oncolytic Newcastle Disease Virus for Canine Intracranial Tumors.
Cancers (Basel). 2024 Jan 29;16(3):564. doi: 10.3390/cancers16030564. PMID: 38339315. Interventional animal study. ˍ




*Hao Z, Wang J, Lv Y, Wu W, Zhang S, Hao S, Chu J, Wan H, Feng J, Ji N.
Identification of MGMT promoter methylation as a specific lipid metabolism biomarker, reveals the feasibility of atorvastatin application in glioblastoma.
Metabolism. 2024 Jan 30;153:155794. doi: 10.1016/j.metabol.2024.155794. PMID: 38301843. Laboratory investigation˰ ˍ








Martín-Fernández J, Moritz-Gasser S, Herbet G, Duffau H.
Is intraoperative mapping of music performance mandatory to preserve skills in professional musicians? Awake surgery for lower-grade glioma conducted from a meta-networking perspective.
Neurosurg Focus. 2024 Feb;56(2):E9. doi: 10.3171/2023.11.FOCUS23702. PMID: 38301246. Case report. ˍ




Yang X, Yan X, Lu Y, Xu Y, Yang L, Li J, Miao W.
Nomogram to Predict the Prognosis of Oligodendroglioma Patients Undergoing Postoperative Adjuvant Chemotherapy.
World Neurosurg. 2024 Feb 1:S1878-8750(24)00142-6. doi: 10.1016/j.wneu.2024.01.120. PMID: 38296045. Observational study˰ ˍ




Perez JL, Naylor RM, Bauman MMJ, Harrison DJ, Knowles K, Burns TC, Lanzino G, Link MJ, Peris Celda M, Meyer FB, Van Gompel J, Parney IF.
Safety of the immediate use of nonsteroidal anti-inflammatory drugs after adult craniotomy for tumor.
J Neurosurg. 2024 Feb 2:1-6. doi: 10.3171/2023.11.JNS231600. PMID: 38306640. Observational study˰ ˍ




Shimoi T, Sunami K, Tahara M, Nishiwaki S, Tanaka S, Baba E, Kanai M, Kinoshita I, Shirota H, Hayashi H, Nishida N, Kubo T, Mamesaya N, Ando Y, Okita N, Shibata T, Nakamura K, Yamamoto N.
Dabrafenib and trametinib administration in patients with BRAF V600E/R or non-V600 BRAF mutated advanced solid tumours (BELIEVE, NCCH1901): a multicentre, open-label, and single-arm phase II trial.
EClinicalMedicine. 2024 Feb 2;69:102447. doi: 10.1016/j.eclinm.2024.102447. PMID: 38333370. Interventional study. ˍ




Zechel C, Loy M, Wegner C, Dahlke E, Soetje B, Baehr L, Leppert J, Ostermaier JJ, Lueg T, Nielsen J, Elßner J, Willeke V, Marzahl S, Tronnier V, Madany Mamlouk A.
Molecular signature of stem-like glioma cells (SLGCs) from human glioblastoma and gliosarcoma.
PLoS One. 2024 Feb 2;19(2):e0291368. doi: 10.1371/journal.pone.0291368. PMID: 38306361. Laboratory investigation. ˍ




Zhang K, Yang T, Xia Y, Guo X, Chen W, Wang L, Li J, Wu J, Xiao Z, Zhang X, Jiang W, Xu D, Guo S, Wang Y, Shi Y, Liu D, Li Y, Wang Y, Xing H, Liang T, Niu P, Wang H, Liu Q, Jin S, Qu T, Li H, Zhang Y, Ma W, Wang Y.
Molecular Determinants of Neurocognitive Deficits in Glioma: Based on 2021 WHO Classification.
J Mol Neurosci. 2024 Feb 5;74(1):17. doi: 10.1007/s12031-023-02173-4. PMID: 38315329. Observational study. ˍ




Chen Y, Ma J, Gao Q, Gai Y, Sun Y, Wang M.
Larotrectinib versus infigratinib for adult patients with both glioma and tyrosine kinase alterations after failure of initial therapies: Efficacy and safety analysis.
Clinics (Sao Paulo). 2024 Feb 7;79:100329. doi: 10.1016/j.clinsp.2024.100329. PMID: 38330791. Observational study. ˍ




Keric N, Krenzlin H, Kalasauskas D, Freyschlag CF, Schnell O, Misch M, von der Brelie C, Gempt J, Krigers A, Wagner A, Lange F, Mielke D, Sommer C, Brockmann MA, Meyer B, Rohde V, Vajkoczy P, Beck J, Thomé C, Ringel F.
Treatment outcome of IDH1/2 wildtype CNS WHO grade 4 glioma histologically diagnosed as WHO grade II or III astrocytomas.
J Neurooncol. 2024 Feb 7. doi: 10.1007/s11060-024-04585-7. PMID: 38326661. Observational study. ˍ




Trkova K, Sumerauer D, Bubenikova A, Krskova L, Vicha A, Koblizek M, Zamecnik J, Jurasek B, Kyncl M, Malinova B, Ondrova B, Jones DTW, Sill M, Strnadova M, Stolova L, Misove A, Benes V 3rd, Zapotocky M.
Clinical and molecular study of radiation-induced gliomas.
Sci Rep. 2024 Feb 7;14(1):3118. doi: 10.1038/s41598-024-53434-0. PMID: 38326438. Observational study. ˍ




Alhalabi OT, Dao Trong P, Kaes M, Jakobs M, Kessler T, Oehler H, König L, Eichkorn T, Sahm F, Debus J, von Deimling A, Wick W, Wick A, Krieg SM, Unterberg AW, Jungk C.
Repeat surgery of recurrent glioma for molecularly informed treatment in the age of precision oncology: A risk-benefit analysis.
J Neurooncol. 2024 Feb 9. doi: 10.1007/s11060-024-04595-5. PMID: 38334907. Observational study. ˍ




Arrillaga-Romany I, Gardner SL, Odia Y, Aguilera D, Allen JE, Batchelor T, Butowski N, Chen C, Cloughesy T, Cluster A, de Groot J, Dixit KS, Graber JJ, Haggiagi AM, Harrison RA, Kheradpour A, Kilburn L, Kurz SC, Lu G, MacDonald TJ, Mehta M, Melemed AS, Nghiemphu PL, Ramage SC, Shonka N, Sumrall A, Tarapore R, Taylor L, Umemura Y, Wen PY.
ONC201 (Dordaviprone) in Recurrent H3 K27M-Mutant Diffuse Midline Glioma.
J Clin Oncol. 2024 Feb 9:JCO2301134. doi: 10.1200/JCO.23.01134. PMID: 38335473. Interventional study. ˍ




Robinson JW, Martin R, Ozawa M, Elwenspoek MMC, Redaniel MT, Kurian K, Ben-Shlomo Y.
Use of drugs for hyperlipidaemia and diabetes and risk of primary and secondary brain tumours: nested case-control studies using the UK Clinical Practice Research Datalink (CPRD).
BMJ Open. 2024 Feb 9;14(2):e072026. doi: 10.1136/bmjopen-2023-072026. PMID: 38336454. Observational study. ˍ




*Ji J, Ding K, Cheng B, Zhang X, Luo T, Huang B, Yu H, Chen Y, Xu X, Lin H, Zhou J, Wang T, Jin M, Liu A, Yan D, Liu F, Wang C, Chen J, Yan F, Wang L, Zhang J, Yan S, Wang J, Li X, Chen G.
Radiotherapy-Induced Astrocyte Senescence Promotes an Immunosuppressive Microenvironment in Glioblastoma to Facilitate Tumor Regrowth.
Adv Sci (Weinh). 2024 Feb 11:e2304609. doi: 10.1002/advs.202304609. PMID: 38342629. Laboratory investigation. ˍ




Traunwieser T, Loos E, Ottensmeier H, Gastberger K, Nemes K, Mynarek M, Bison B, Kandels D, Neumayer P, Neumann-Holbeck A, Lüttich P, Baust K, Faulstich-Ritter K, John R, Kreisch A, Landmann J, Manteufel E, Nest A, Prüfe J, Schubert L, Stamm W, Timmermann B, Gerss J, Rutkowski S, Schlegel PG, Eyrich M, Gnekow AK, Frühwald MC.
Survivors of infant atypical teratoid/rhabdoid tumors present with severely impaired cognitive functions especially for fluid intelligence and visual processing: data from the German brain tumor studies.
Pediatr Blood Cancer. 2024 Feb 11:e30910. doi: 10.1002/pbc.30910. PMID: 38342954. Observational study. ˍ




*Castellani G, Buccarelli M, D'Alessandris QG, Ilari R, Cappannini A, Pedini F, Boe A, Lulli V, Parolini I, Giannetti S, Biffoni M, Zappavigna V, Marziali G, Pallini R, Ricci-Vitiani L.
Extracellular vesicles produced by irradiated endothelial or Glioblastoma stem cells promote tumor growth and vascularization modulating tumor microenvironment.
Cancer Cell Int. 2024 Feb 12;24(1):72. doi: 10.1186/s12935-024-03253-0. PMID: 38347567. Laboratory investigation. ˍ




Koay JM, Michaelides L, Moniz-Garcia DP, Quinones-Hinojosa A, Chaichana K, Almeida JP, Gruenbaum BF, Sherman WJ, Sabsevitz DS.
Repeated surgical resections for management of high-grade glioma and its impact on quality of life.
J Neurooncol. 2024 Feb 13. doi: 10.1007/s11060-024-04600-x. PMID: 38349476. Observational study. ˍ